Paul Harmatz, M.D.October 16, 2020

Paul Harmatz, M.D. – FDA 483, Oct 16, 2020

Record Details

An FDA inspection of Paul Harmatz, M.D. in Oakland, CA, a clinical investigator, revealed a significant issue with informed consent documentation. The inspection found that written informed consent forms were not properly signed by subjects or their legally authorized representatives, including instances where ad hoc translations were used without proper signatures or witness attestations. This indicates a failure to adhere to proper clinical trial documentation practices.

Company: Paul Harmatz, M.D.
Inspection date: October 16, 2020
Product type: drugs
Office: Division of Human and Animal Food Operations - West V
Person: Kristin M. Abaonza

View Company Profile

ID · 4be550aa-04d7-4658-a54a-258d02328940

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Paul Harmatz, M.D.